Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
These medications target one receptor, the GLP-1 receptor
Obesity significantly elevates the risk of conditions such as type 2 diabetes, hypertension and cardiovascular disorders, creating stronger demand for treatments capable of producing sustained weight loss and improving overall metabolic health
UK Evidence & Safety Weight loss injections, particularly GLP-1 receptor agonists like semaglutide (Wegovy) and liraglutide (Saxenda), are increasingly prescribed in the UK for obesity management
Semaglutide is an FDA-approved medication that mimics GLP-1, a naturally occurring hormone in the body
Fortunato JJ, Rus GZ, Kirsch TR, Stringari RB, Stertz L, Kapczinski F, et al
Compounded semaglutide is not
US$ 24.71
US$ 26.74
US$ 29.92
US$ 25.02
